TACR1 and glioblastoma: Hence, this study aimed to explore the possible effect of the SP/NK1R system and aprepitant, a potent NK1R antagonist, on the expression and activity of catalase and superoxide dismutase enzymes, two of the most well-known antioxidant enzymes, in U87 glioblastoma cancer cells.